No advantage of increased SSRI dose seen for treatment-resistant panic disorder
Study: Antiepileptics do not increase risk of suicide attempts in bipolar patients
Raltegravir and lamotrigine
Cardiometabolic risk with antipsychotic use in children and teens
Tarenflurbil for cognitive decline in patients with mild AD
Commentary by Naomi M. Simon, M.D., M.Sc.
News Notes
Olanzapine-induced tardive oculogyric crisis
From the FDA